Reuters logo
BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie
2017年4月25日 / 下午12点31分 / 5 个月前

BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie

April 25 (Reuters) - Aquinnah Pharmaceuticals:

* Aquinnah Pharmaceuticals receives $10 million investment from Pfizer and Abbvie to research breakthrough approach to neurodegenerative disease

* $10 million adds to an earlier $5 million investment made by Takeda pharmaceuticals in December 2015

* Pfizer Inc and Abbvie Inc have invested in co’s work to treat ALS, Alzheimer’s disease and other neurodegenerative diseases Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below